California Stem Cell Directors Take Up Klein's New Role, Future Priorities
An old saying in the world of governance and politics goes like this: “The king is dead. Long live the king.”
It all has to do with transition, power and, in the case of the California stem cell agency, possibly new initiatives.
On Dec. 1, those issues and more will be on the table publicly at the agency. The CIRM directors' Governance Subcommittee is sc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.